ATLANTA--(BUSINESS WIRE)--Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories – public and private financings, fast growing companies, acquisitions and SBIR grants – reflecting a broad range of activity.
